Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI)-CONICET, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Argentina.
Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI)-CONICET, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Argentina.
Biochim Biophys Acta Mol Basis Dis. 2020 May 1;1866(5):165706. doi: 10.1016/j.bbadis.2020.165706. Epub 2020 Jan 24.
Host resistance during infection with Trypanosoma cruzi, and other protozoans, is dependent on a balanced immune response. Robust immunity against these pathogens requires of the concerted action of many innate and adaptive cell populations including macrophages, neutrophils, dendritic cells, CD4, and CD8 T cells and B cells among others. Indeed, during most protozoan infections only a balanced production of inflammatory (T1) and anti-inflammatory (T2/regulatory) cytokines will allow the control of parasite spreading without compromising host tissue integrity. The description of T17 cells, a novel effector helper T cell lineage that produced IL-17 as signature cytokine, prompted the revision of our knowledge about the mechanisms that mediate protection and immunopathology during protozoan infections. In this manuscript we discuss the general features of IL-17 mediated immune responses as well as the cellular sources, effector mechanisms and overall role of IL-17 in the immune response to T. cruzi and other protozoan infections.
宿主在感染克氏锥虫和其他原生动物时的抵抗力取决于平衡的免疫反应。针对这些病原体的强大免疫力需要许多先天和适应性细胞群体的协同作用,包括巨噬细胞、嗜中性粒细胞、树突状细胞、CD4 和 CD8 T 细胞以及 B 细胞等。事实上,在大多数原生动物感染中,只有平衡产生炎症(T1)和抗炎(T2/调节)细胞因子才能在不损害宿主组织完整性的情况下控制寄生虫的扩散。T17 细胞的描述,即一种新型效应辅助 T 细胞谱系,其特征细胞因子是产生白细胞介素 17(IL-17),促使我们修订了关于在原生动物感染过程中介导保护和免疫病理学的机制的知识。在本文中,我们讨论了 IL-17 介导的免疫反应的一般特征,以及细胞来源、效应机制以及 IL-17 在针对克氏锥虫和其他原生动物感染的免疫反应中的总体作用。